Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Novartis
Novartis
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Children's Oncology Group
Children's Oncology Group
AbbVie
Children's Cancer Group, China
Center for International Blood and Marrow Transplant Research
Novartis
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
Orca Biosystems, Inc.
Servier
Children's Oncology Group
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pennsylvania
University of Miami
Baylor College of Medicine
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Children's Oncology Group
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Bambino Gesù Hospital and Research Institute
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
City of Hope Medical Center
University of Pennsylvania
Baylor College of Medicine
UNC Lineberger Comprehensive Cancer Center